Rockville-based Novavax reports larger quarterly loss

Novavax Inc., of Rockville, a drug delivery company developing vaccines aimed at a broad range of infectious diseases worldwide, reported a net loss of $10 million, or 7 cents per diluted share, for the first quarter of 2013, compared to a net loss of $7.3 million, or 6 cents per share, for the year-ago period.

Leave a Reply

Your email address will not be published. Required fields are marked *


You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>


Scroll To Top